Cart
sales@molnova.com
Home - Products - Others - Other Targets - Lesinurad

Lesinurad

CAS No. 878672-00-5

Lesinurad( RDEA594 )

Catalog No. M19217 CAS No. 878672-00-5

Lesinurad is a selective inhibitor of uric acid reabsorption which is used in combination with other agents in the therapy of gout.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 35 In Stock
25MG 69 In Stock
50MG 122 In Stock
100MG 197 In Stock
200MG 294 In Stock
500MG 493 In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Lesinurad
  • Note
    Research use only, not for human use.
  • Brief Description
    Lesinurad is a selective inhibitor of uric acid reabsorption which is used in combination with other agents in the therapy of gout.
  • Description
    Lesinurad is a selective inhibitor of uric acid reabsorption which is used in combination with other agents in the therapy of gout. Lesinurad has had a limited clinical use but has not been associated with serum enzyme elevations during therapy or with instances of clinically apparent liver injury.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    RDEA594
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    OAT1| OAT3
  • Research Area
    Metabolic Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    878672-00-5
  • Formula Weight
    404.28
  • Molecular Formula
    C17H14BrN3O2S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 39 mg/mL; 96.47 mM
  • SMILES
    C1CC1c1ccc(c2ccccc12)n1c(nnc1Br)SCC(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Tan, et al.[abstract]. Arthritis Rheum 2013;65 Suppl 10 :1723.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Seviteronel R enanti...

    Seviteronel R enantiomer (VT-464 R enantiomer) is a Seviteronel isomer produced during the manufacturing process.

  • GSK-626616

    GSK-626616 is a potent and orally bioavailable DYRK3 inhibitor (IC50: 0.7 nM). It inhibits other members of the DYRK family with similar potency. GSK-626616 is a potential therapy for the treatment of anemia.

  • Ro 48-8071

    A potent 2,3-oxidosqualene cyclase (OSC) inhibitor with IC50 of 6.5 nM.

Sign In Join Free